Although it has been shown that EBF1 expression is decreased in the brain with AD, which affects the transcriptional level of FAM3C and promotes Aβ deposition (Watanabe et al., 2021), there are very few studies on the association of EBF1 with AD. This evidence concerns the gene FAM3C and Alzheimer disease.